Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K
RNA Interference01:23

RNA Interference

27.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.8K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

7.5K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A molecularly engineered rhenium platform triggers a self-enhancing RNS storm to disrupt tumor hypoxia and resultant immunosuppression.

Chemical science·2026
Same author

THz spectroscopy and deviation from Drude model of LT-GaAs thin films with sub-picosecond charge-carrier lifetime.

Faraday discussions·2026
Same author

Antibacterial mechanisms of magnolol against Streptococcus agalactiae and immunomodulatory effects in Schizothorax prenanti.

Fish & shellfish immunology·2026
Same author

[Discovery and preliminary verification of direct targets of active ingredients of Shuangshen Ningxin Capsules in preventing and treating myocardial ischemia-reperfusion injury].

Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica·2026
Same author

In Situ Decoding of Vitrimer Topological Evolution: A Non-Invasive, External Stress-Free Approach via Hierarchical CNT Sensing Networks.

ACS applied materials & interfaces·2026
Same author

Clinical Analysis of Comprehensive Pharmacotherapy Combined With Ultrasound-Guided Precise Lesion Resection Plus Primary Microplasty in the Treatment of Nonpuerperal Mastitis.

The breast journal·2026

Related Experiment Video

Updated: Jan 16, 2026

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
12:43

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE

Published on: July 29, 2014

12.7K

Ru(II) Complex-Mediated Phase Separation Amplifies Photocatalytic RNA Damage to Stimulate RIG‑I Immunotherapy.

Xiao-Xiao Chen1, Xia Mu2, Zhi-Yuan Li1

  • 1MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, Sun Yat-Sen University, Guangzhou 510006, P. R. China.

JACS Au
|October 2, 2025
PubMed
Summary

Researchers developed a novel Ruthenium(II) complex (Ru1) that induces RNA phase separation. This discovery offers a new strategy for cancer treatment by activating immune responses through RNA photodamage.

Keywords:
antitumorphase separationphotodynamic therapyruthenium complextumor immune microenvironments

More Related Videos

Capture and Identification of RNA-binding Proteins by Using Click Chemistry-assisted RNA-interactome Capture CARIC Strategy
09:36

Capture and Identification of RNA-binding Proteins by Using Click Chemistry-assisted RNA-interactome Capture CARIC Strategy

Published on: October 19, 2018

9.8K
mRNA Interactome Capture from Plant Protoplasts
12:29

mRNA Interactome Capture from Plant Protoplasts

Published on: July 28, 2017

9.6K

Related Experiment Videos

Last Updated: Jan 16, 2026

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
12:43

Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE

Published on: July 29, 2014

12.7K
Capture and Identification of RNA-binding Proteins by Using Click Chemistry-assisted RNA-interactome Capture CARIC Strategy
09:36

Capture and Identification of RNA-binding Proteins by Using Click Chemistry-assisted RNA-interactome Capture CARIC Strategy

Published on: October 19, 2018

9.8K
mRNA Interactome Capture from Plant Protoplasts
12:29

mRNA Interactome Capture from Plant Protoplasts

Published on: July 28, 2017

9.6K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Chemical Biology

Background:

  • RNA phase separation is crucial for cellular processes like transcription and translation.
  • Dysregulation of RNA phase separation is linked to diseases, including cancer.
  • Small molecule inducers of RNA phase separation are needed for therapeutic applications.

Purpose of the Study:

  • To design and synthesize a novel Ruthenium(II) complex (Ru1) capable of inducing RNA phase separation.
  • To investigate the mechanism of Ru1-induced RNA phase separation and its effect on RNA-centric immune activation.
  • To evaluate the therapeutic potential of Ru1 in improving tumor immune microenvironments.

Main Methods:

  • Synthesis and characterization of the Ru(II) complex (Ru1).
  • In vitro studies to assess Ru1's ability to induce phase separation of double-stranded RNA (dsRNA) and single-stranded RNA (ssRNA).
  • Molecular dynamics simulations to understand the role of ligand substituents in RNA binding and phase separation.
  • Assessment of Ru1-mediated immune activation via the retinoic-acid-inducible gene I (RIG-I) pathway following photoactivation.
  • In vivo studies to evaluate the impact of Ru1 on tumor immune microenvironments.

Main Results:

  • The designed Ru(II) complex (Ru1) effectively induces phase separation of both dsRNA and ssRNA in vitro.
  • Ligand substituents, specifically positively charged triphenylphosphine and hydroxyl groups, are critical for Ru1's RNA phase separation capability.
  • Ru1-mediated phase separation followed by photoactivation triggers an RNA-centric immune response via the RIG-I pathway.
  • Ru1 treatment significantly enhances tumor immune microenvironments.

Conclusions:

  • Ruthenium(II) complex (Ru1) is the first small molecule reported to induce RNA phase separation.
  • Ru1 offers a novel platform for RNA-targeted cancer immunotherapy by combining phase separation with photoactivation.
  • The findings suggest Ru1 as a promising therapeutic agent for improving anti-tumor immunity.